¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"irreversible change"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • irreversible change
    ºñ°¡¿ªº¯È­
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • change
    º¯È­
  • exothermic change
    ¹ß¿­º¯È­
  • fatty change
    Áö¹æº¯È­
  • irreversible
    ºñ°¡¿ª-
  • irreversible colloid
    ºñ°¡¿ªÄÝ·ÎÀ̵å
  • irreversible gel
    ºñ°¡¿ª°Ö
  • irreversible inhibition
    ºñ°¡¿ª¾ïÁ¦
  • irreversible reaction
    ºñ°¡¿ª¹ÝÀÀ
  • irreversible shock
    ºñ°¡¿ª¼îÅ©
  • minimal change disease
    ¹Ì¼¼º¯È­º´
  • malignant change
    ¾Ç¼ºº¯È­
  • reversible change
    °¡¿ªº¯È­
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • irreversible change
    ºñ°¡¿ªº¯È­
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • change
    º¯È­
  • exothermic change
    ¹ß¿­º¯È­
  • fatty change
    Áö¹æº¯¼º
  • malignant change
    ¾Ç¼ºº¯È­
  • reversible change
    °¡¿ªº¯È­
  • minimal change disease
    ÃÖ¼Òº¯È­ÄáÆÏº´Áõ
  • time zone change syndrome
    (¢¡jet lag syndrome) ºñÇà½ÃÂ÷ÁõÈıº
  • irreversible colloid
    ºñ°¡¿ªÄÝ·ÎÀ̵å
  • irreversible damage
    ºñ°¡¿ª¼Õ»ó
  • irreversible obstructive lung disease
    ºñ°¡¿ªÆó¼âÆóº´
  • irreversible gel
    ºÒ°¡¿ª°Ö
  • irreversible
    ºñ°¡¿ª¼º-
  • irreversible inhibition
    ºÒ°¡¿ªÀúÁö
  • irreversible reaction
    ºÒ°¡¿ª¹ÝÀÀ
  • irreversible shock
    ºñ°¡¿ª¼îÅ©
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Irreversible shock
    ºñ°¡¿ªÀû(ުʦæ½îÜ) ¼ï
  • Climactic change
    °»³â±â¼º º¯È­
  • frequency change
    Á֯ļö º¯È­
  • genotypic change
    À¯ÀüÀÚÇüº¯ÀÌ.
  • hypertensive change
    °íÇ÷¾Ð¼º º¯È­ ¾ÈÀú(äÑî¼)ÀÇ .
  • phasic change
    À§»ó¼º º¯È­(êÈßÓàõܨûù).
  • physical change
    ¹°¸®º¯È­(ÚªìµÜ¨ûù).
  • rachitic change
    ±¸·ç¼º º¯È­( ×§àõܨûù).
  • rachitic change
    ±¸·ç¼º º¯È­(±¸×§àõܨûù)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • irreversible change
    ºñ°¡¿ª¼º(ުʦæ½àõ) º¯È­(ܨûù).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • irreversible
    ºÒ°¡¿ª¼ºÀÇ.
  • irreversible
    ºñ°¡¿ª¼º(ުʦæ½àõ), ȸº¹ºÒ´É(üÞÜÖÝÕÒö)ÀÇ.¾à¸®ºÒ°¡¿ª¼º(ÝÕ?
  • irreversible colloid
    ºñ°¡¿ª¼º ÄÝ·ÎÀ̵å.
  • irreversible damage
    ºñ°¡¿ªÀû ¼Õ»ó(ުʦæ½îÜáßß¿).
  • irreversible gel
    ºÒ°¡¿ª¼º °Ö.
  • irreversible inhibition
    ºÒ°¡¿ªÀúÇØ.
  • irreversible obstructive lung disease
    ºñ°¡¿ª¼º Æó¼â¼º ÆóÁúȯ(¡­øÍáðàõøËòð ü´).
  • irreversible reaction
    ºÒ°¡¿ª¹ÝÀÀ.
  • irreversible shock
    ºñ°¡¿ª¼ï.
  • atmospheric pressure change
    ´ë±â¾Ð º¯È­(ÓÞѨäâܨûù)
  • change
    º¯È­(ܨûù), º¯Á¶ (ܨðà).
  • change
    º¯È­(ËÒÌ´), º¯Á¶ (ËÒÌ¡).
  • exothermic change
    ¹ß¿­º¯È­(Û¡æðܨûù).
  • exothermic change
    ¹ß¿­º¯È­.
  • fatty change
    Áö¹æ º¯¼º(¡­Ü¨à÷)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • enthalpy change
    ¿£Å»ÇÇ º¯È­(ܨûù)
  • entropy change
    ¿£Æ®·ÎÇÇ º¯È­(ܨûù)
  • free energy change
    ÀÚÀ¯(í»ë¦) ¿¡³ÊÁö º¯È­(ܨûù)
  • standard enthalpy change
    Ç¥ÁØ(øöñÞ) ¿£Å»ÇÇ º¯È­(ܨûù)
  • standard entropy change
    Ç¥ÁØ(øöñÞ) ¿£Æ®·ÎÇÇ º¯È­(ܨûù)
  • standard free energy change
    Ç¥ÁØ(øöñÞ) ÀÚÀ¯(í»ë¦)¿¡³ÊÁö º¯È­(ܨûù)
  • active site-directed irreversible inhibitor
    Ȱ¼º(üÀàõ)ÀÚ¸®ÁöÇâÀû ºÒ°¡¿ªÀúÇØÁ¦(ò¦ú¾îÜÝÕʦæ½îÁúªð¥)
  • irreversible antagonist
    ºñ°¡¿ª ±æÇ×Á¦(ުʦæ½ÑÏù÷ð¥)
  • irreversible inhibitor
    ºñ°¡¿ª ÀúÇØÁ¦(ުʦæ½îÁúªð¥)
  • irreversible process
    ºñ°¡¿ª °úÁ¤(ުʦæ½Î¦ïï)
  • irreversible reaction
    ºñ°¡¿ª ¹ÝÀÀ(ުʦæ½Úãëë)
  • irreversible shock
    ºñ°¡¿ª(ުʦæ½)¼ï
  • irreversible thermodynamics
    ºñ°¡¿ª ¿­¿ªÇÐ(ÞªÊ¦æ½æðÕôùÊ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • irreversible
    ºñ°¡¿ª¼ºÀÇ, ȸº¹ºÒ´ÉÀÇ, ºÒ°¡¿ª¼ºÀÇ
  • change
    º¯È­, º¯Á¶
  • frequency change
    Á֯ļöº¯È­
  • malignant change
    ¾Ç¼ºº¯È­
  • reversible change
    °¡¿ªº¯È­
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
KW change Keith Wagener change
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
ILR interleukin receptor; irreversible loss rate
MCD   1) Minimal Change Disease
  2) Menstrual Cycle Day
MCL Minimal Change Disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ILR irreversible loss rate
CGI-C Clinical Global Impression of Change
FAC Fractional area change
HSC Health System Change
MCD Minimal change disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • irreversible
    ºñ°¡¿ª¼º, ȸº¹ ºÒ´ÉÀÇ, ºÒ°¡¿ª¼ºÀÇ, ºñ°¡¿ªÀû
    °¡¿ªÀûÀ¸·Î µÇ´Â °ÍÀÌ ºÒ°¡´ÉÇÑ.
  • irreversible colloid
    ºñ°¡¿ª¼º ÄÝ·ÎÀ̵å
  • irreversible gel
    ºÒ°¡¿ª¼º °Ö
  • irreversible occlusal therapy
    ºñ°¡¿ªÀûÀÎ ±³ÇÕ Ä¡·á, ºñ°¡¿ªÀû ±³ÇÕ Ä¡·á
  • irreversible pulpitis
    ºñ°¡¿ª¼º Ä¡¼ö¿°
    1. ÇØ·Î¿î Àڱؿ¡ ÀÇÇØ ¾ß±âµÇ´Â Ä¡¼öÀÇ Áö¼ÓÀûÀÎ ¿°ÁõÁ¦¿¡ ÀÇÇØ µ¿Åë À¯¹ß. ÀÚ¹ßÅë ¹ß»ý. 2. Ä¡¼ö ±«»ç·Î ÁøÇàµÈ Ä¡¼ö ¿°ÁõÀº ÀÚ¹ßÅë, ¿ÜºÎ ÀÚ±Ø ÈÄ ºÒÆí°¨ÀÌ °è¼ÓµÇ¸ç °¡¿ªÀû Ä¡¼ö¿°°ú ºñ±³ ½Ã ´õ¿í ½ÉÇÑ ºÒÆí°¨ÀÌ ³ªÅ¸³­´Ù. °©ÀÛ½º·± ÀÚ¼¼ º¯È­ ÈÄ µ¿Åë Á¤µµÀÇ ±ØÀûÀÎ Áõ°¡´Â ºñ°¡¿ªÀû Ä¡¼ö¿°ÀÇ ÀüÇüÀû Áõ»óÀ̸ç Áõ»óÀÌ °³¼±µÇ´Â µí ÇÏ´Ù°¡ Á¤µµ°¡ Á¡Â÷ ÁøÇàµÇ¸ç ¾ÐÅëÀº ¿©ÀüÈ÷ Á¸ÀçÇÑ´Ù. ³Ã, ¿Â, Àü±â Ãæ°ÝÀ¸·Î Ä¡¼ö °Ë»ç ½Ã µ¿ÅëÀÌ Áö¼ÓµÈ´Ù. ÁøÀüµÈ ºñ°¡¿ªÀû Ä¡¼ö¿°ÀÇ °æ¿ì ³ÃÀÚ±ØÀÌ µ¿ÅëÀ» °æ°¨½Ãų ¼öµµ ÀÖ´Ù. Ä¡·á´Â ¹ßÄ¡¿Í ±Ù°ü Ä¡·áÁß ¾çÀÚ ÅÃÀÏÇÑ´Ù.
  • black change
    Èæ»ö º¯È­
  • blue-black change
    Ã»Èæ º¯È­
  • brown change
    °¥»ö º¯È­
  • brownish change
    °¥»ö º¯È­
  • change
    º¯È­, º¯Á¶
  • change over time
    ½Ã°£¿¡ µû¸¥ º¯È­
  • color change
    º¯»ö, »öÁ¶ º¯È­
  • compensatory change
    ´ë»ó¼º º¯È­
  • dental change
    Ä¡¾Æ º¯È­
  • dysplastic change
    ÀÌÇü¼º º¯È­
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
irreversible Incapable of being reversed.
(18 Nov 1997)
irreversible colloid A colloid that is not again soluble in water after having been dried at ordinary temperature.
Synonym: unstable colloid.
(05 Mar 2000)
irreversible hydrocolloid A hydrocolloid whose physical state is changed by an irreversible chemical reaction when water is added to a powder and an insoluble substance is formed.
(05 Mar 2000)
irreversible process <chemistry> Any real process, when a system undergoes the changes State 1 - greater than State 2 - greater than State 1 by any real pathway, the universe is different that before the cyclic process took place in the system.
(09 Jan 1998)
irreversible reaction A reaction or response by the tissues to a pathogenic agent characterised by a permanent pathologic change.
(05 Mar 2000)
irreversible shock Shock that has progressed beyond the stage when it will respond to transfusion or other form of treatment, and recovery is impossible.
(05 Mar 2000)
Armanni-Ebstein change Glycogen vacuolization of the loops of Henle, seen in diabetics before the introduction of insulin.
Synonym: Armanni-Ebstein change.
(05 Mar 2000)
Baggenstoss change Distention of pancreatic acini by proteinaceous secretion, seen in dehydration.
(05 Mar 2000)
change An alteration; in pathology, structural alteration of which the cause and significance is uncertain.
Synonym: shift.
(05 Mar 2000)
change of life Colloquialism for menopause, climacteric.
(05 Mar 2000)
chemical change A process in which one or more substances are changed into one or more different substances.
(09 Oct 1997)
minimal-change disease <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure.
This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness.
It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown.
Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy.
Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
Synonym: lipoid nephrosis
(27 Sep 1997)
minimal-change nephrotic syndrome <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure.
This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness.
It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown.
Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy.
Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
Synonym: lipoid nephrosis
(27 Sep 1997)
conformational change <cell biology> Alteration in the shape usually the tertiary structure of a protein as a result of alteration in the environment pH, temperature, ionic strength) or the binding of a ligand (to a receptor) or binding of substrate (to an enzyme).
(18 Nov 1997)
Crooke's hyaline change Replacement of cytoplasmic granules of basophil cells of the anterior pituitary by homogenous hyaline material; a characteristic finding in Cushing's syndrome, but usually not present in the cells of a basophil adenoma.
Synonym: Crooke's hyaline degeneration.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • irreversible
    °Å²Ù·Î ÇÒ ¼ö ¾ø´Â
  • irreversible
    °Å²Ù·Î ÇÒ(µÚÁýÀ») ¼ö¾ø´Â;¿ªÀü(¿ªÇà)ÇÒ¼ö ¾ø´Â;öȸ(Ãë¼Ò)ÇÒ¼ö ¾ø´Â;º¯°æÇÒ¼ö ¾ø´Â
  • amount of change
    ¸¹Àº Àܵ·(µ¿Àü)
  • change
    º¯È­,±³È¯,º¯È­ÇÏ´Ù,±³È¯ÇÏ´Ù,Àܵ·,µ¿Àü
  • change hands
    ÁÖÀÎÀÌ ¹Ù²î´Ù
  • change
    ¹Ù²Ù´Ù;º¯È­½ÃŰ´Ù;º¯°æÇÏ´Ù;°íÄ¡´Ù;(¿ÊÀ»)...À¸·Î °¥¾Æ ÀÔ´Ù;(ħ´ëÀÇ)½ÃÆ®¸¦ °¥´Ù;(¾î¸°¾ÆÀÌÀÇ)±âÀú±Í¸¦ °¥´Ù;ȯÀüÇÏ´Ù;Àܵ·À¸·Î ¹Ù²Ù´Ù;(¼öÇ¥.¾îÀ½.ȯÀ»)Çö±ÝÀ¸·Î ¹Ù²Ù´Ù;±³È¯ÇÏ´Ù;(Àå¼Ò.ÀÔÀåµîÀ»)¹Ù²Ù´Ù;(Å»°ÍÀ»)°¥¾ÆÅ¸´Ù;¹Ù²ãŸ´Ù;º¯ÇÏ´Ù;¹Ù²î´Ù;º¯È­ÇÏ´Ù;(´Þ.Á¶¼öµîÀÌ)
  • change gear
    (ÀÚµ¿Â÷.±â°èÀÇ)º¯¼Ó±â ÀåÄ¡
  • change machine
    Àܵ· ±³È¯±â
  • change ringing
    (±³È¸ µîÀÇ)ÀüÁ¶ ¸íÁ¾(¹ý)(Á¾À» ¿©·¯°¡Áö À½»ö,ƯÈ÷ 4ºÐÀ½°è·Î ¿ï¸®±â)
  • change wheel
    Àüȯ Åé´Ï¹ÙÄû 
  • change-down
    (ÀÚµ¿Â÷µîÀÇ ±â¾î¸¦)Àú¼ÓÀ¸·Î ¹Ù²Ù±â
  • change-of-ends
    üÀÎÁöÄÚÆ®;ÄÚÆ®±³Ã¼
  • change-up
    üÀÎÁö¾÷(ŸÀÚÀÇ Å¸À̹ÖÀ» ¾î±ß³ª°Ô Çϱâ À§ÇØ ¼Ó±¸ °°Àº ¸ð¼ÇÀ¸·Î ´øÁö´Â ¿Ï±¸)
  • functional change
    ±â´É Àüȯ
  • gear change
    (ƯÈ÷ ÀÚµ¿Â÷ÀÇ)º¯¼Ó·¹¹ö;±â¾î Àüȯ ÀåÄ¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á